GILD

Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
$145.68
-3.18 (-2.14%)
Mkt Cap: 180.87B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield6.2%
Dividend YieldN/A
Market Cap180.87B
Volume3.95M
Recent News
BNP Paribas Purchases 20,329 Shares of Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-29
Beacon Pointe Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-29
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
zacks.com · 2026-08-28
Bamco Inc. NY Sells 12,000 Shares of Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-28
US FDA approves Gilead's once-daily combination pill for HIV treatment
reuters.com · 2026-08-27
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
cnbc.com · 2026-08-27

Unlock the Full Deep Scan

9 AI agents analyze GILD across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →